{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:57:49Z","timestamp":1785859069717,"version":"3.56.0"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.mpa.0000188307.67420.46","type":"journal-article","created":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T04:02:12Z","timestamp":1134100932000},"page":"1-8","source":"Crossref","is-referenced-by-count":16,"title":["Bone Marrow-Induced Tolerance in the Era of Pancreas and Islets Transplantation"],"prefix":"10.1097","volume":"32","author":[{"given":"Spiros","family":"Delis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210212","first-page":"489","article-title":"Studies on heterologous antilymphocyte serum in mice: VII. Optimal cellular antigen for induction of immunologic tolerance with ALS.","volume":"2","author":"Monaco","year":"1970","journal-title":"Transplant Proc"},{"key":"R2-1-20210212","first-page":"1312","article-title":"Attempt to induce unresponsiveness to human renal allografts with antilymphocyte globulin and donor-specific bone marrow.","volume":"27","author":"Monaco","year":"1985","journal-title":"Transplant Proc"},{"key":"R3-1-20210212","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-199101000-00011","article-title":"Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.","volume":"51","author":"Barber","year":"1991","journal-title":"Transplantation"},{"key":"R4-1-20210212","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00007890-199306000-00012","article-title":"Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.","volume":"55","author":"Starzl","year":"1993","journal-title":"Transplantation"},{"key":"R5-1-20210212","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0167-5699(96)10070-0","article-title":"The lost chord: microchimerism and allograft survival.","volume":"17","author":"Starzl","year":"1996","journal-title":"Immunol Today"},{"key":"R6-1-20210212","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199908270-00006","article-title":"Combined histocompatible leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.","volume":"68","author":"Spitzer","year":"1999","journal-title":"Transplantation"},{"key":"R7-1-20210212","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","article-title":"Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression.","volume":"13","author":"Butcher","year":"1999","journal-title":"Clin Transplant"},{"key":"R8-1-20210212","doi-asserted-by":"crossref","first-page":"954","DOI":"10.7326\/0003-4819-114-11-954","article-title":"Immunologic tolerance to renal allografts after bone marrow transplants from the same donors.","volume":"114","author":"Sayegh","year":"1991","journal-title":"Ann Intern Med"},{"key":"R9-1-20210212","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(94)91881-3","article-title":"Tolerance to an HLA-B, DR disparate kidney allograft after bone-marrow transplantation from same donor.","volume":"1","author":"Jacobsen","year":"1994","journal-title":"Lancet"},{"key":"R10-1-20210212","first-page":"1420","article-title":"Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.","volume":"58","author":"Helg","year":"1994","journal-title":"Transplantation"},{"key":"R11-1-20210212","first-page":"1633","article-title":"Renal transplantation without chronic immunosuppression after T-cell-depleted, HLA-mismatched bone marrow transplantation.","volume":"59","author":"Sorof","year":"1995","journal-title":"Transplantation"},{"key":"R12-1-20210212","first-page":"8","article-title":"Against all odds, Elly saves Rhondas life twice-once as bone marrow donor, later as kidney donor.","volume":"9","author":"Grygotis","year":"1999","journal-title":"Newslett"},{"key":"R13-1-20210212","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","article-title":"Mini-allografts: ongoing trials in humans.","volume":"25","author":"Carella","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R14-1-20210212","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00007890-200106150-00031","article-title":"Tolerance in renal transplantation after allogeneic bone marrow transplantation-6 year follow-up.","volume":"71","author":"Sellers","year":"2001","journal-title":"Transplantation"},{"key":"R15-1-20210212","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.52.1.353","article-title":"Mixed chimerism and transplantation tolerance.","volume":"52","author":"Wekerle","year":"2001","journal-title":"Annu Rev Med"},{"key":"R16-1-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4049\/jimmunol.136.1.28","article-title":"Effect of selective T cell depletion of host and\/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2 B10).","volume":"136","author":"Ildstad","year":"1986","journal-title":"J Immunol"},{"key":"R17-1-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.162.1.231","article-title":"Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.","volume":"162","author":"Ildstad","year":"1985","journal-title":"J Exp Med"},{"key":"R18-1-20210212","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00007890-199810270-00001","article-title":"A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.","volume":"66","author":"Neipp","year":"1998","journal-title":"Transplantation"},{"key":"R19-1-20210212","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0140-6736(92)91840-5","article-title":"Cell migration, chimerism and graft acceptance.","volume":"339","author":"Starzl","year":"1992","journal-title":"Lancet"},{"key":"R20-1-20210212","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0167-5699(96)10069-4","article-title":"Chimerism and transplantation tolerance: cause and effect.","volume":"17","author":"Wood","year":"1996","journal-title":"Immunol Today"},{"key":"R21-1-20210212","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007890-198511000-00021","article-title":"Karyotypic chimerism and rejection in a pancreaticoduodenosplenic transplant.","volume":"40","author":"Dafoe","year":"1985","journal-title":"Transplantation"},{"key":"R22-1-20210212","first-page":"210","article-title":"Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells.","volume":"27","author":"Rao","year":"1995","journal-title":"Transplant Proc"},{"key":"R23-1-20210212","first-page":"3387","article-title":"Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation.","volume":"27","author":"Rao","year":"1995","journal-title":"Transplant Proc"},{"key":"R24-1-20210212","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0041-1345(96)00552-0","article-title":"Three years of follow-up of bone marrow-augmented organ transplant recipients: The impact of donor-specific immune modulation.","volume":"29","author":"Zeevi","year":"1997","journal-title":"Transplant Proc"},{"key":"R25-1-20210212","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00000658-199909000-00010","article-title":"Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.","volume":"230","author":"Corry","year":"1999","journal-title":"Ann Surg"},{"key":"R26-1-20210212","first-page":"3121","article-title":"Donor bone marrow infusion in simultaneous pancreas\/kidney transplant recipients: a preliminary study.","volume":"27","author":"Burke","year":"1995","journal-title":"Transplant Proc"},{"key":"R27-1-20210212","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0041-1345(96)00553-2","article-title":"Donor bone marrow infusion in simultaneous pancreas\/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.","volume":"29","author":"Burke","year":"1997","journal-title":"Transplant Proc"},{"key":"R28-1-20210212","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0041-1345(97)01394-8","article-title":"Higher percentage of donor CD34+ expression in peripheral blood of simultaneous pancreas\/kidney\/donor bone marrow versus than kidney\/islet cell\/ donor bone marrow recipients.","volume":"30","author":"Burke","year":"1998","journal-title":"Transplant Proc"},{"key":"R30-1-20210212","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00007890-199610270-00021","article-title":"Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.","volume":"62","author":"Garcia-Morales","year":"1996","journal-title":"Transplantation"},{"key":"R31-1-20210212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bmt.1703110","article-title":"Immunoregulatory role of chimerism in clinical organ transplantation.","volume":"28","author":"Mathew","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R32-1-20210212","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0031-3955(03)00120-2","article-title":"Kirk Atolerance: is it achievable in pediatric solid organ transplantation?","volume":"50","author":"Pearl","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"R33-1-20210212","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00007890-200202270-00004","article-title":"Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats.","volume":"73","author":"Ikebukuro","year":"2002","journal-title":"Transplantation"},{"key":"R34-1-20210212","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/diabetes.50.4.710","article-title":"Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.","volume":"50","author":"Ryan","year":"2001","journal-title":"Diabetes"},{"key":"R35-1-20210212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1634\/stemcells.20-1-86","article-title":"Localized bone marrow transplantation leads to skin allograft acceptance in nonmyeloablated recipients: comparison of intra-bone marrow and isolated limb perfusion.","volume":"20","author":"Askenasy","year":"2002","journal-title":"Stem Cells"},{"key":"R36-1-20210212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI11015","article-title":"Tolerance to solid organ transplants through transfer of MHC class II genes.","volume":"107","author":"Sonntag","year":"2001","journal-title":"J Clin Invest"},{"key":"R37-1-20210212","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI11969","article-title":"The tolerant recipient: looking good in someone elses genes (editorial).","volume":"107","author":"Rosengard","year":"2001","journal-title":"J Clin Invest"},{"key":"R38-1-20210212","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.16.1.619","article-title":"How do monoclonal antibodies induce tolerance? A role for infectious tolerance?","volume":"16","author":"Waldmann","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"R39-1-20210212","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0140-6736(94)92583-6","article-title":"Peripheral microchimerism in long-term cadaveric-kidney allograft recipients.","volume":"343","author":"Suberbielle","year":"1994","journal-title":"Lancet"},{"key":"R40-1-20210212","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.TP.0000058516.74246.71","article-title":"Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.","volume":"75","author":"Li","year":"2003","journal-title":"Transplantation"},{"key":"R41-1-20210212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00007890-200207150-00005","article-title":"Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.","volume":"74","author":"Wu","year":"2002","journal-title":"Transplantation"},{"key":"R42-1-20210212","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.TP.0000057832.92231.F5","article-title":"A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.","volume":"75","author":"Guo","year":"2003","journal-title":"Transplantation"},{"key":"R43-1-20210212","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1634\/stemcells.18-4-273","article-title":"Long term analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.","volume":"18","author":"Hayashi","year":"2000","journal-title":"Stem Cells"},{"key":"R44-1-20210212","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self tolerance.","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"R45-1-20210212","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0952-7915(98)80084-8","article-title":"Control of immune pathology by regulatory T cells.","volume":"10","author":"Mason","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"R46-1-20210212","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmunity.","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R47-1-20210212","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00007890-198307000-00021","article-title":"Renal allograft tolerance induced with ATG and donor bone marrow in out-bred rhesus monkeys.","volume":"36","author":"Thomas","year":"1983","journal-title":"Transplantation"},{"key":"R48-1-20210212","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00007890-199709150-00008","article-title":"Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.","volume":"64","author":"Kimikawa","year":"1997","journal-title":"Transplantation"},{"key":"R49-1-20210212","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1097\/00007890-200004271-00991","article-title":"Costimulatory blockade for induction of mixed chimerism and renal allograft tolerance in non-human primates.","volume":"69","author":"Kawai","year":"2000","journal-title":"Transplantation"},{"key":"R50-1-20210212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0008-8749(89)90016-6","article-title":"Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 P1) irradiation chimeras.","volume":"121","author":"Ruedi","year":"1989","journal-title":"Cell Immunol"},{"key":"R51-1-20210212","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.157.7.2820","article-title":"Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.","volume":"157","author":"Colson","year":"1996","journal-title":"J Immunol"},{"key":"R52-1-20210212","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0797-783","article-title":"Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning.","volume":"3","author":"Sykes","year":"1997","journal-title":"Nat Med"},{"key":"R53-1-20210212","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1182\/blood.V88.12.4601.bloodjournal88124601","article-title":"Mechanism of cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vbeta T-cells receptor repertoire by both host and donor bone marrow-derived cells.","volume":"88","author":"Colson","year":"1997","journal-title":"Blood"},{"key":"R54-1-20210212","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00007890-199504270-00013","article-title":"Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.","volume":"59","author":"Burlingham","year":"1995","journal-title":"Transplantation"},{"key":"R55-1-20210212","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1098\/rstb.2001.0851","article-title":"Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation.","volume":"356","author":"Field","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R56-1-20210212","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/83393","article-title":"Immunity or tolerance: opposite outcomes of microchimerism from skin grafts.","volume":"7","author":"Anderson","year":"2001","journal-title":"Nat Med"},{"key":"R57-1-20210212","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI119240","article-title":"The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.","volume":"99","author":"Garcia-Morales","year":"1997","journal-title":"J Clin Invest"},{"key":"R58-1-20210212","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00007890-199804150-00016","article-title":"Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.","volume":"65","author":"Garcia-Morales","year":"1998","journal-title":"Transplantation"},{"key":"R59-1-20210212","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00007890-199910270-00001","article-title":"The human bone marrow as an immunoregulatory organ.","volume":"68","author":"Miller","year":"1999","journal-title":"Transplantation"},{"key":"R60-1-20210212","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00007890-200104150-00002","article-title":"Six-year clinical effect of donor bone marrow infusions in renal transplant patients.","volume":"71","author":"Ciancio","year":"2001","journal-title":"Transplantation"},{"key":"R61-1-20210212","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00007890-200012270-00003","article-title":"Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipients antidonor immune responses.","volume":"70","author":"Mathew","year":"2000","journal-title":"Transplantation"},{"key":"R62-1-20210212","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/stemcells.18-5-320","article-title":"The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells.","volume":"18","author":"Kronenwett","year":"2000","journal-title":"Stem Cells"},{"key":"R63-1-20210212","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood.V84.8.2436.2436","article-title":"Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.","volume":"84","author":"Kaufinan","year":"1994","journal-title":"Blood"},{"key":"R64-1-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(01)00456-1","article-title":"Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity.","volume":"106","author":"Liu","year":"2001","journal-title":"Cell"},{"key":"R65-1-20210212","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells.","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"key":"R66-1-20210212","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/00007890-200105150-00027","article-title":"Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth.","volume":"71","author":"Takayama","year":"2001","journal-title":"Transplantation"},{"key":"R67-1-20210212","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal cells: nature, biology, and potential applications.","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"key":"R68-1-20210212","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy.","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"key":"R69-1-20210212","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1097\/01.TP.0000067955.60639.D5","article-title":"Tolerance induction in clinical transplantation: the pending questions.","volume":"75","author":"Toungouz","year":"2003","journal-title":"Transplantation"},{"key":"R70-1-20210212","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.167.4.2087","article-title":"Predominance of NK1.1+TCR+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: Natural suppressor cells.","volume":"167","author":"Lan","year":"2001","journal-title":"J Immunol"},{"key":"R71-1-20210212","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood.V94.9.3222","article-title":"Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.","volume":"94","author":"Waller","year":"1999","journal-title":"Blood"},{"key":"R72-1-20210212","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood.V99.11.4174","article-title":"Tolerance induction by megadose hematopoietic progenitor cells: Expansion of veto cells by short term culture of purified human CD34(+) cells.","volume":"99","author":"Gur","year":"2002","journal-title":"Blood"},{"key":"R73-1-20210212","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00007890-199560120-00009","article-title":"Combined simultaneous kidney\/bone marrow transplantation.","volume":"60","author":"Shapiro","year":"1995","journal-title":"Transplantation"},{"key":"R74-1-20210212","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V97.10.2948","article-title":"Larger numbers of CD4 bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.","volume":"97","author":"Waller","year":"2001","journal-title":"Blood"},{"key":"R75-1-20210212","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/74731","article-title":"Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.","volume":"6","author":"Wekerle","year":"2000","journal-title":"Nat Med"},{"key":"R76-1-20210212","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.bmt.1701153","article-title":"The effect of T cell depletion with Campath-1 M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.","volume":"21","author":"Lowdell","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R77-1-20210212","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00075200-200109000-00012","article-title":"Pathogenesis and prevention of graft-versus-host disease.","volume":"6","author":"Teshima","year":"2001","journal-title":"Curr Opin Organ Transplant"},{"key":"R78-1-20210212","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00075200-200109000-00011","article-title":"Reduced-intensity conditioning in allogeneic transplantation for the elderly (55 years) with matched related or unrelated donors.","volume":"6","author":"Finke","year":"2001","journal-title":"Curr Opin Organ Transplant"},{"key":"R79-1-20210212","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses.","volume":"94","author":"Childs","year":"1999","journal-title":"Blood"},{"key":"R80-1-20210212","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0041-1345(03)00206-9","article-title":"Tolerance protocols and cell transplantation:prospects for the clinic.","volume":"35","author":"Calne","year":"2003","journal-title":"Transplant Proc"},{"key":"R81-1-20210212","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s002680010127","article-title":"Prope Tolerance: A step in the search for tolerance in the clinic.","volume":"24","author":"Calne","year":"2000","journal-title":"World J Surg"},{"issue":"suppl","key":"R82-1-20210212","first-page":"470","article-title":"Sirolimus monotherapy in kidney transplantation following high dose thymoglobulin induction.","volume":"3","author":"Swanson","year":"2002","journal-title":"Am J Transplant"},{"issue":"suppl","key":"R83-1-20210212","first-page":"459","article-title":"Campath-1H induction plus rapamycin monotherapy in renal transplantation.","volume":"3","author":"Knechtle","year":"2002","journal-title":"Am J Transplant"},{"key":"R84-1-20210212","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.TP.0000112436.26473.A2","article-title":"Targeted bone marrow radioablation with Samarium-Lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.","volume":"77","author":"Inverardi","year":"2004","journal-title":"Transplantation"},{"key":"R85-1-20210212","first-page":"415","article-title":"Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival.","volume":"108","author":"Kamel","year":"1990","journal-title":"Surgery"},{"key":"R86-1-20210212","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.4049\/jimmunol.134.6.3656","article-title":"Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells.","volume":"134","author":"Qian","year":"1985","journal-title":"J Immunol"},{"key":"R87-1-20210212","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/15256","article-title":"Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral tolerance.","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med"},{"key":"R88-1-20210212","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/83175","article-title":"CTLA-4 up-regulation plays a role in tolerance mediated by CD45.","volume":"2","author":"Fecteau","year":"2001","journal-title":"Nat Immunol"},{"key":"R89-1-20210212","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0198-8859(99)00002-6","article-title":"Trans vivo analysis of human delayed-type hypersensitivity reactivity.","volume":"60","author":"Carrodeguas","year":"1999","journal-title":"Hum Immunol"},{"key":"R90-1-20210212","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(96)09105-2","article-title":"Microchimerism and rejection in clinical transplantation.","volume":"349","author":"Elwood","year":"1997","journal-title":"Lancet"},{"key":"R91-1-20210212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-0012.1999.130206.x","article-title":"Prospective study of microchimerism in transplant recipients.","volume":"13","author":"McDaniel","year":"1999","journal-title":"Clin Transplant"},{"key":"R92-1-20210212","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-199708150-00010","article-title":"Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism.","volume":"64","author":"Sivasai","year":"1997","journal-title":"Transplantation"},{"key":"R93-1-20210212","first-page":"577","article-title":"Response to Wood and Sachs.","volume":"17","author":"Starzl","year":"1996","journal-title":"Immunol Today"},{"key":"R94-1-20210212","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.174.1.542","article-title":"Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.","volume":"174","author":"Adams","year":"2005","journal-title":"J Immunol"},{"key":"R95-1-20210212","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.TP.0000054835.58014.C2","article-title":"Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.","volume":"75","author":"Haanstra","year":"2003","journal-title":"Transplantation"},{"key":"R96-1-20210212","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/01.TP.0000116392.72152.75","article-title":"Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.","volume":"77","author":"Kanmaz","year":"2004","journal-title":"Transplantation"},{"key":"R97-1-20210212","first-page":"5","article-title":"Clinical kidney transplantation in 1984.","volume":"17","author":"Monaco","year":"1985","journal-title":"Transplant Proc"},{"key":"R99-1-20210212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1072-7515(98)00053-2","article-title":"Will xenotransplantation ever be feasible?","volume":"186","author":"Starzl","year":"1998","journal-title":"J Am Coll Surg"},{"issue":"Suppl 174","key":"R100-1-20210212","first-page":"24","article-title":"Can acute rejection be prevented in SPK transplant recipients? Preliminary results in a single center, randomized prospective trial.","volume":"33","author":"Burke","year":"2001","journal-title":"Acta Chir Austr"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001665-201203000-00107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:04:42Z","timestamp":1785855882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006676-200601000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mpa.0000188307.67420.46","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}